Skip to main content
Log in

Non-Aqueous Suspensions of Antibodies are Much Less Viscous Than Equally Concentrated Aqueous Solutions

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to markedly lower the viscosities of highly concentrated protein, in particular antibody, formulations. An effective approach elaborated herein for γ-globulin and a monoclonal antibody is to replace aqueous solutions with equimolar suspensions in neat organic solvents.

Methods

Viscosities of aqueous solutions and non-aqueous suspensions of the model protein bovine γ-globulin and a murine monoclonal antibody were examined under a variety of experimental conditions. In addition, protein particle sizes were measured using dynamic light scattering and light microscopy.

Results

Concentrated suspensions of amorphous γ-globulin powders (up to 300 mg/mL, composed of multi-micron-sized particles) in absolute ethanol and a number of other organic solvents were found to have viscosities up to 38 times lower than the corresponding aqueous solutions. Monoclonal antibody follows the same general trend. Additionally, the higher the protein concentration and lower the temperature, the greater the viscosity benefit of a suspension over a solution.

Conclusions

The viscosities of concentrated γ-globulin and monoclonal antibody suspensions in organic solvents are drastically reduced compared to the corresponding aqueous solutions; the magnitude of this reduction depends on the solvent, particularly its hydrogen-bonding properties.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

MAb:

Monoclonal antibody

References

  1. Beck A, Wurch T, Bailly C, Corvaia N. Strategies and challenges for the next generation of therapeutic antibodies. Nature Revs Immunol. 2010;10:345–52.

    Article  CAS  Google Scholar 

  2. Weiner LM, Surana R, Wang S. Monoclonal antibodies: versatile platforms for cancer immunotherapy. Nature Revs Immunol. 2010;10:317–27.

    Article  CAS  Google Scholar 

  3. Ahamed T, Esteban BNA, Ottens M, van Dedem GWK, van der Wielen LAM, Bisschops MAT, et al. Phase behavior of an intact monoclonal antibody. Biophys J. 2007;93:610–9.

    Article  PubMed  CAS  Google Scholar 

  4. Yang MX, Shenoy B, Disttler M, Patel R, McGrath M, Pechenov S, et al. Crystalline monoclonal antibodies for subcutaneous delivery. Proc Natl Acad Sci U S A. 2003;100:6934–9.

    Article  PubMed  CAS  Google Scholar 

  5. Shire SJ, Shahrokh Z, Liu J. Challenges in the development of high protein concentration formulations. J Pharm Sci. 2004;93:1390–402.

    Article  PubMed  CAS  Google Scholar 

  6. Du W, Klibanov AM. Hydrophobic salts markedly diminish viscosity of concentrated protein solutions. Biotechnol Bioeng. 2011;108:632–6.

    Article  PubMed  CAS  Google Scholar 

  7. Guo Z, Chen A, Nassar RA, Helk B, Mueller C, Tang Y, et al. Structure-activity relationship for hydrophobic salts as viscosity-lowering excipients for concentrated solutions of monoclonal antibodies. Pharm Res. 2012;29:3102–9.

    Article  PubMed  CAS  Google Scholar 

  8. Miller MA, Engstrom JD, Ludher BS, Johnston KP. Low viscosity highly concentrated injectable nonaqueous suspension of lysozyme microparticles. Langmuir. 2010;26:1067–74.

    Article  PubMed  CAS  Google Scholar 

  9. Johnston KP, Maynard JA, Truskett TM, Borwankar AU, Miller MA, Wilson BK, et al. Concentrated dispersion of equilibrium protein nanoclusters that reversibly dissociate into active monomers. ACS Nano. 2012;6:1357–69.

    Article  PubMed  CAS  Google Scholar 

  10. Basu SK, Govardhan CP, Jung CW, Margolin AL. Protein crystals for the delivery of biopharmaceuticals. Expert Op Biol Ther. 2004;4:301–17.

    Article  CAS  Google Scholar 

  11. He F, Becker GW, Litowski JR, Narhi LO, Brems DN, Razinkov VI. High throughput dynamic light scattering methods for measuring viscosity of concentrated protein solutions. Anal Biochem. 2010;399:141–3.

    Article  PubMed  CAS  Google Scholar 

  12. Krieger IM, Dougherty TJ. A mechanism for non-Newtonian flow in suspensions of rigid spheres. Trans Soc Rheol. 1959;3:137–52.

    Article  CAS  Google Scholar 

  13. Patel AR, Kerwin BA, Kanapuram SR. Viscoelastic characterization of high concentration antibody formulations using quartz crystal microbalance with dissipation monitoring. J Pharm Sci. 2009;98:3108–16.

    Article  PubMed  CAS  Google Scholar 

  14. Kanai S, Liu J, Patapoff HW, Shire SJ. Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity. J Pharm Sci. 2008;97:4219–27.

    Article  PubMed  CAS  Google Scholar 

  15. Yadav S, Shire SJ, Kalonia DS. Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies. J Pharm Sci. 2010;99:4812–29.

    Article  PubMed  CAS  Google Scholar 

  16. Patel HM, Kraszewski JL, Mukhopadhyay B. The phosphoenolpyruvate carboxylase from Methanothermobacter thermautotrophicus has a novel structure. J Bacteriol. 2004;186:5129–37.

    Article  PubMed  CAS  Google Scholar 

  17. Englard S, Seifter S. Precipitation techniques. Meth Enzymol. 1990;182:285–300.

    Article  PubMed  CAS  Google Scholar 

  18. Matheus S, Friess W, Schwartz D, Mahler H-C. Liquid high concentration IgG1 antibody formulations by precipitation. J Pharm Sci. 2009;98:3043–57.

    Article  PubMed  CAS  Google Scholar 

  19. Frokjaer S, Otzen DE. Protein drug stability: a formulation challenge. Nature Revs Drug Discov. 2005;4:298–306.

    Article  CAS  Google Scholar 

  20. Van Oss CJ. On the mechanism of the cold ethanol precipitation method of plasma protein fractionation. J Protein Chem. 1989;8:6661–8.

    Article  Google Scholar 

  21. Klibanov AM. Improving enzymes by using them in organic solvents. Nature. 2001;409:241–6.

    Article  PubMed  CAS  Google Scholar 

  22. Foster TP, Moseley WM, Caputo JF, Alaniz GR, Leatherman MW, Yu X, et al. Sustained elevated serum somatotropin concentrations in Holstein steers following subcutaneous delivery of a growth hormone releasing factor analog dispersed in water, oil or microspheres. J Control Rel. 1997;47:91–9.

    Article  CAS  Google Scholar 

  23. FDA. Inactive ingredient search for approved drug products. November 23, 2012. Available from: http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm.

  24. Bowen M, Armstrong N, Ma Y-F. Investigating high-concentration monoclonal antibody powder suspension in nonaqueous suspension vehicles for subcutaneous injection. J Pharm Sci. 2012;101:4433–43.

    Article  PubMed  CAS  Google Scholar 

  25. Dai W, Hill B, Liu K, Mieczkowski C. Non-aqueous high concentration reduced viscosity suspension formulations of antibodies. US Patent Application 2012; 0 076 800.

Download references

Acknowledgments and Disclosures

This study was financially supported by the Sanofi-Aventis pharmaceutical company. We also thank the MIT Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems (funded by NSF-0070319 and NIH GM68762 instrumentation grants).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander M. Klibanov.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Srinivasan, C., Weight, A.K., Bussemer, T. et al. Non-Aqueous Suspensions of Antibodies are Much Less Viscous Than Equally Concentrated Aqueous Solutions. Pharm Res 30, 1749–1757 (2013). https://doi.org/10.1007/s11095-013-1017-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-013-1017-4

KEY WORDS

Navigation